Orlistat
Product Quick Detail
- Place Of Origin
- China(Shanghai）
- Minimum Order
- 1
- Packaging
- aluminum foil packing
- Delivery
- 3~5 Days
Specifications
E-mail:lisayi@sdwenhou.com
WhatsApp：+86 15562519051
Wickr：Beatayi
| Product Name | Orlistat |
| Synonyms |
Tetrahydrolipstatin MFCD05662360 Allileucinate Orlistat Orlipastat Orlipastatum L-Leucine, Xenical (-)-Tetrahydrolipstatin THLP |
| CAS NO | 96829-58-2 |
| ENIENCS | 200-961-8 |
| Molecular Formula | C29H53NO5 |
| Molecular Weight | 495.735 |
| Melting point | <50ºC |
| Boiling Point | 615.9±30.0 °C at 760 mmHg |
| Flash Point | 326.3±24.6 °C |
| Density | 1.2±0.1 g/cm3 |
| Assay | 99% |
| Grade | Pharmaceutical Grade |
| Solubility | N/A |
| Appearance | white solid |
| Storage | Keep storage sealed, store in a cool, dry place, and ensure good ventilation or exhaust in the workshop |
| Packaging and Shipping | Aluminum foil bag, cartons, plastic contain,drums or as required; By Express, by Air, by Sea according to the Amount. |
| Usage | Orlistat is a lipase inhibitor used to control obesity, which works by inhibiting the absorption of dietary fat |
- Country: China (Mainland)
- Business Type: 贸易公司
- Market:美洲,欧洲
- Founded Year:2021
- Address:
- Contact:Beata
Other products from Shandong Wenhou Trading Co., LTD
Relate products of Orlistat
Orlistat
ProName: Orlistat CasNo: 96829-58-2 Molecular Formula: C29H53NO5 Appearance: White to off-white crystalline powder Application: It is an important raw material and in... DeliveryTime: prompt PackAge: according to the clients requirement Port: Shanghai ProductionCapacity: 1-1000 ...
Orlistat(CAS:96829-58-2)
产品名称 工厂供应商减肥奥利司他 120 胶囊原料粉末 外貌 白色或白色结晶性粉末 化验 99%min 奥利司他胶囊 测试 高效液相色谱 证书 ISO 9001 中国科学院 96829-58-2 中频 C17H19N3O3S 艾涅克公司没有 115074-43-6 剂型： ...
Orlistat
Product Details Place of Origin: Hebei, China Model Number: Pharmaceutical Intermediates, Purity: 99.5%min MF: C29H53NO5 Other Names: Orlistat CAS No.: 96829-58-2 Usage: Animal Pharmaceuticals Grade Standard: Medicine Grade The first picture is the product description above, ...
